[Biopharmaceutical industry's commitment to innovation and to the future of health care].
Since the last century pharmaceuticals has been an industry of intensive innovation. If able to afford the sharp increase in the resources needed to face transformed prospects and processes of drug discovery and development, and if supported by an improved regulatory innovation-centered framework, biopharma firms remain--prospectively, too--the engine of industrial innovation in health care.